Skip to navigation Skip to content
  • Woodruff
  • Business
  • Health Sciences
  • Law
  • MARBL
  • Oxford College
  • Theology
  • Schools
    • Undergraduate

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing

      Community

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing
    • Graduate

      • Business School
      • Graduate School
      • School of Law
      • School of Medicine
      • School of Nursing
      • School of Public Health
      • School of Theology
  • Libraries
    • Libraries

      • Robert W. Woodruff
      • Business
      • Chemistry
      • Health Sciences
      • Law
      • MARBL
      • Music & Media
      • Oxford College
      • Theology
    • Library Tools

      • Course Reserves
      • Databases
      • Digital Scholarship (ECDS)
      • discoverE
      • eJournals
      • Electronic Dissertations
      • EmoryFindingAids
      • EUCLID
      • ILLiad
      • OpenEmory
      • Research Guides
  • Resources
    • Resources

      • Administrative Offices
      • Emory Healthcare
      • Academic Calendars
      • Bookstore
      • Campus Maps
      • Shuttles and Parking
      • Athletics: Emory Eagles
      • Arts at Emory
      • Michael C. Carlos Museum
      • Emory News Center
      • Emory Report
    • Resources

      • Emergency Contacts
      • Information Technology (IT)
      • Outlook Web Access
      • Office 365
      • Blackboard
      • OPUS
      • PeopleSoft Financials: Compass
      • Careers
      • Human Resources
      • Emory Alumni Association
  • Browse
    • Works by Author
    • Works by Journal
    • Works by Subject
    • Works by Dept
    • Faculty by Dept
  • For Authors
    • How to Submit
    • Deposit Advice
    • Author Rights
    • Publishing Your Data
    • FAQ
    • Emory Open Access Policy
    • Open Access Fund
  • About OpenEmory
    • About OpenEmory
    • About Us
    • Citing Articles
    • Contact Us
    • Privacy Policy
    • Terms of Use
 
Contact Us

Filter Results:

Year

  • 2014 (1)

Author

  • Dingledine, Raymond (1)
  • Ganesh, Thota (1)
  • Yang, Myung-Soon (1)

Subject

  • Health Sciences, Pharmacology (1)
  • Health Sciences, Pharmacy (1)

Journal

  • Journal of Medicinal Chemistry (1)

Keyword

  • 2 (1)
  • activ (1)
  • alzheim (1)
  • alzheimersdiseas (1)
  • amyotroph (1)
  • amyotrophiclateralsclerosi (1)
  • arthriti (1)
  • biomedicin (1)
  • braininjuri (1)
  • chemistri (1)
  • collagen (1)
  • collageninduc (1)
  • damag (1)
  • diseas (1)
  • ep (1)
  • epilepticus (1)
  • inflammatori (1)
  • injuri (1)
  • later (1)
  • life (1)
  • medicin (1)
  • microgli (1)
  • oxid (1)
  • pharmaci (1)
  • pharmacolog (1)
  • process (1)
  • prostaglandin (1)
  • prostanoid (1)
  • receptor (1)
  • sclerosi (1)
  • status (1)
  • technolog (1)
  • traumat (1)

Author department

  • Pharmacology: Admin (1)

Search Results for all work with filters:

  • Jiang, Jianxiong
  • Health Sciences, General
  • scienc
  • brain
  • induc

Work 1 of 1

Sorted by relevance

Article

Lead Optimization Studies of Cinnamic Amide EP2 Antagonists

by Thota Ganesh; Jianxiong Jiang; Myung-Soon Yang; Raymond Dingledine

2014

Subjects
  • Health Sciences, Pharmacology
  • Health Sciences, Pharmacy
  • Health Sciences, General
  • File Download
  • View Abstract

Abstract:Close

Prostanoid receptor EP2 can play a proinflammatory role, exacerbating disease pathology in a variety of central nervous system and peripheral diseases. A highly selective EP2 antagonist could be useful as a drug to mitigate the inflammatory consequences of EP2 activation. We recently identified a cinnamic amide class of EP2 antagonists. The lead compound in this class (5d) displays anti-inflammatory and neuroprotective actions. However, this compound exhibited moderate selectivity to EP2 over the DP1 prostanoid receptor (∼10-fold) and low aqueous solubility. We now report compounds that display up to 180-fold selectivity against DP1 and up to 9-fold higher aqueous solubility than our previous lead. The newly developed compounds also display higher selectivity against EP4 and IP receptors and a comparable plasma pharmacokinetics. Thus, these compounds are useful for proof of concept studies in a variety of models where EP2 activation is playing a deleterious role. © 2014 American Chemical Society.
Site Statistics
  • 16,813
  • Total Works
  • 3,638,724
  • Downloads
  • 1,114,635
  • Downloads This Year
  • 6,807
  • Faculty Profiles

Copyright © 2016 Emory University - All Rights Reserved
540 Asbury Circle, Atlanta, GA 30322-2870
(404) 727-6861
Privacy Policy | Terms & Conditions

v2.2.8-dev

Contact Us Recent and Popular Items
Download now